FIRST TR EXCHNG TRADED FD VI - SMITH UNCONSTRAI (UCON)

CUSIP: 33740F888

Q4 2023 13F Holders as of 31 Dec 2023

Share change
+11,291,820
SEC-reported price per share
$24.74
Number of holders
212
Value change
+$279,998,456
Number of buys
134
Number of sells
79

Security key

33740F888

Report period

Q4 2023

Institutions

212

Top holders

10

Ownership snapshot

Top reported holders of UCON - FIRST TR EXCHNG TRADED FD VI - SMITH UNCONSTRAI (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
212
Shares
64,995,777
Rows available
212
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
197
Q4 2023 holders
212
Holder diff
15
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .